secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001493152-25-001567
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics prices $4.25M public offering of 5M shares at $0.85/share
--------------------------------------------------------------------------------

- Priced public offering of 5,000,000 shares at $0.85 per share for gross proceeds of $4.25 million.
- Ladenburg Thalmann acting as exclusive placement agent; fees include 8% cash fee plus 1% management fee.
- Placement agent warrants issued to purchase 250,000 shares at $1.0625 per share (125% of offering price).
- Lock-up agreements: company 15 days, directors/officers 90 days from closing; agent may waive.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315225001567/0001493152-25-001567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315225001567/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer